bluebird bio (BLUE) PT Lowered to $14 at RBC Capital
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 26
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on bluebird bio (NASDAQ: BLUE) to $14.00 (from $26.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Plains GP Holdings, L.P (PAGP) PT Raised to $28 at Morgan Stanley
- Williams Companies (WMB) PT Raised to $103 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
